Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -663.04x is 435% below its 5-year average of -123.85x, near the low end of its 5-year range (-663.04x–356.15x).
812.94% below its 12-month average of -72.63x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): 356.15x.
INTEREST COVERAGE RATIO
-663.04x
INTEREST COVERAGE RATIO AVG TTM
-72.63x
INTEREST COVERAGE RATIO AVG 3Y
-142.19x
INTEREST COVERAGE RATIO AVG 5Y
-123.85x
INTEREST COVERAGE RATIO AVG 10Y
-46.45x
INTEREST COVERAGE RATIO AVG 15Y
-73.19x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-812.94%
CURRENT VS 3Y AVG
-366.30%
CURRENT VS 5Y AVG
-435.35%
CURRENT VS 10Y AVG
-1327.34%
CURRENT VS 15Y AVG
-805.89%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 524 covered companies
CURRENT VS SECTOR MEDIAN
-10300.63%
vs the sector median at left
iBio, Inc.
Market Cap
$67.20M
Interest Coverage Ratio
-663.04x
TTM Avg
-72.63x
3Y Avg
-142.19x
5Y Avg
-123.85x
Market Cap
$68.08M
Interest Coverage Ratio
-1174.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$66.31M
Interest Coverage Ratio
-632.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.18M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$66.20M
Interest Coverage Ratio
-21.57x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.32M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.41M
Interest Coverage Ratio
-14.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $67.20M | -663.04x | -72.63x | -142.19x | -123.85x |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.08M | -1174.00x | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $66.31M | -632.78x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.18M | -8.06x | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $66.20M | -21.57x | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.32M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.75M | N/A | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $64.43M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.41M | -14.86x | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.92M | N/A | N/A | N/A | N/A |
Interest Coverage
-663.0x
Debt/Equity
0.03
Current Ratio
7.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 356.15x |
| 2026-03-31 | -266.45x |
| 2025-12-31 | -169.39x |
| 2025-09-30 | -165.31x |
| 2025-06-30 | -118.14x |
| 2025-03-31 | -90.35x |
| 2024-12-31 | -77.53x |
| 2024-09-30 | -72.04x |
| 2024-06-30 | -56.82x |
| 2024-03-31 | -69.73x |
| 2023-12-31 | -132.24x |
| 2023-09-30 | -196.27x |
| 2023-06-30 | -292.06x |
| 2023-03-31 | -176.26x |
| 2022-12-31 | -341.06x |
| 2022-06-30 | -75.09x |
| 2021-09-30 | -8.58x |
| 2021-06-30 | -15.40x |
| 2021-03-31 | -11.77x |
| 2020-12-31 | -12.27x |
| 2020-09-30 | -11.28x |
| 2020-06-30 | -4.76x |
| 2020-03-31 | -6.60x |
| 2019-12-31 | -5.13x |
| 2019-09-30 | -6.22x |
| 2019-06-30 | -8.55x |
| 2019-03-31 | -7.95x |
| 2018-12-31 | -8.43x |
| 2018-09-30 | -8.30x |
| 2018-06-30 | -8.26x |
| 2018-03-31 | -7.31x |
| 2017-12-31 | -7.15x |
| 2017-09-30 | -7.00x |
| 2017-06-30 | -8.01x |
| 2017-03-31 | -8.18x |
| 2016-12-31 | -6.88x |
| 2016-09-30 | -6.53x |
| 2016-06-30 | -5.69x |
| 2016-03-31 | -9.51x |
| 2013-06-30 | -30.76x |
| 2013-03-31 | -124.00x |
| 2012-12-31 | -97.13x |
| 2012-09-30 | -117.48x |
| 2012-06-30 | -115.73x |
| 2012-03-31 | -121.76x |
| 2011-12-31 | -159.17x |
| 2011-09-30 | -242.79x |
| 2011-06-30 | -210.59x |
| 2011-03-31 | -375.46x |
| 2010-12-31 | -144.28x |
| 2010-09-30 | -104.46x |
| 2010-06-30 | -127.01x |
| 2009-09-30 | -28600.00x |
